Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Jubilant Stock Holding Pvt Ltd Newspaper advertisements for result of postal ballot
Jubilant Life Sciences Ltd has submitted to BSE a copies of Newspaper advertisements for result of postal ballot. Disclosure of Voting results of Postal Ballot (Regulation 44(3) of SEBI (LODR) Regulations, 2015)
Jubilant Life Sciences Ltd has informed BSE regarding the details of Voting results of Postal Ballot, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Closure of Trading Window
Jubilant Life Sciences Ltd has informed BSE that pursuant to the Companys Code of Conduct for Prevention of Insider Trading, the Trading Window for dealing in the securities of the Company will be closed for Designated Persons from December 26, 2016 and the same will remain closed till 48 hours after the announcement of the unaudited financial results for the quarter ending December 31, 2016 to the Stock Exchanges.... Jubilant Life Sciences Announces Price Hike Of Up To 15%
Jubilant Life Sciences is engaged in pharmaceuticals, life science ingredients and drug discovery solutions. Jubilant Life Sciences announces price increase of up to 15% for Beta Picoline, 3-Cyanopyridine and Vitamin B3 (Niacin & Niacinamide)
Jubilant Life Sciences Ltd has informed BSE regarding a Press Release dated December 20, 2016 titled "Jubilant Life Sciences announces price increase of up to 15% for Beta Picoline, 3-Cyanopyridine and Vitamin B3 (Niacin & Niacinamide)". Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Jubilant Stock Holding Pvt Ltd Exercise of ESOP Options
Jubilant Life Sciences Ltd has informed BSE that 1,64,604 options under JLL Employees Stock Option Plan 2011 ("Plan 2011") have been exercised by the option holders.Pursuant to the terms of Plan 2011, the Nomination, Remuneration and Compensation Committee of the Company (the "Committee") has approved transfer of 1,64,604 equity shares of Re. 1 each of Jubilant Life Sciences Limited from Jubilant Employees Welfare Trust to the eligible option holders. Newspaper Advertisement for Postal Ballot
Jubilant Life Sciences Ltd has submitted to BSE a copy of newspaper advertisement for Postal Ballot. Issuance of Commercial Papers of Rs. 50 crore
Jubilant Life Sciences Ltd has informed BSE that the Company has issued Commercial Papers ('CPs) of Rs. 50 crore on November 25, 2016.